Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 242

1.

Type I IFNs control antigen retention and survival of CD8α(+) dendritic cells after uptake of tumor apoptotic cells leading to cross-priming.

Lorenzi S, Mattei F, Sistigu A, Bracci L, Spadaro F, Sanchez M, Spada M, Belardelli F, Gabriele L, Schiavoni G.

J Immunol. 2011 May 1;186(9):5142-50. doi: 10.4049/jimmunol.1004163. Epub 2011 Mar 25.

2.

Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.

Galea-Lauri J, Wells JW, Darling D, Harrison P, Farzaneh F.

Cancer Immunol Immunother. 2004 Nov;53(11):963-77. Epub 2004 May 14.

PMID:
15146294
3.

Influenza A infection enhances cross-priming of CD8+ T cells to cell-associated antigens in a TLR7- and type I IFN-dependent fashion.

Wei J, Waithman J, Lata R, Mifsud NA, Cebon J, Kay T, Smyth MJ, Sadler AJ, Chen W.

J Immunol. 2010 Nov 15;185(10):6013-22. doi: 10.4049/jimmunol.1002129. Epub 2010 Oct 18.

4.

CpG promotes cross-presentation of dead cell-associated antigens by pre-CD8α+ dendritic cells [corrected].

de Brito C, Tomkowiak M, Ghittoni R, Caux C, Leverrier Y, Marvel J.

J Immunol. 2011 Feb 1;186(3):1503-11. doi: 10.4049/jimmunol.1001022. Epub 2010 Dec 27. Erratum in: J Immunol. 2011 Jun 15;186(12):7272.

5.

Anatomic location defines antigen presentation by dendritic cells to T cells in response to intravenous soluble antigens.

Chung Y, Chang JH, Kim BS, Lee JM, Kim HY, Kang CY.

Eur J Immunol. 2007 Jun;37(6):1453-62.

6.
7.

IFN-alpha-conditioned dendritic cells are highly efficient in inducing cross-priming CD8(+) T cells against exogenous viral antigens.

Lapenta C, Santini SM, Spada M, Donati S, Urbani F, Accapezzato D, Franceschini D, Andreotti M, Barnaba V, Belardelli F.

Eur J Immunol. 2006 Aug;36(8):2046-60.

8.

CD8alpha+ DC are not the sole subset cross-presenting cell-associated tumor antigens from a solid tumor.

McDonnell AM, Prosser AC, van Bruggen I, Robinson BW, Currie AJ.

Eur J Immunol. 2010 Jun;40(6):1617-27. doi: 10.1002/eji.200940153.

9.
10.

Selection of an antibody library identifies a pathway to induce immunity by targeting CD36 on steady-state CD8 alpha+ dendritic cells.

Tagliani E, Guermonprez P, Sepúlveda J, López-Bravo M, Ardavín C, Amigorena S, Benvenuti F, Burrone OR.

J Immunol. 2008 Mar 1;180(5):3201-9.

11.

Type I IFN-induced, NKT cell-mediated negative control of CD8 T cell priming by dendritic cells.

Bochtler P, Kröger A, Schirmbeck R, Reimann J.

J Immunol. 2008 Aug 1;181(3):1633-43.

13.

Antigen encoded by vaccine vectors derived from human adenovirus serotype 5 is preferentially presented to CD8+ T lymphocytes by the CD8α+ dendritic cell subset.

Suleman M, Galea S, Gavard F, Merillon N, Klonjkowski B, Tartour E, Richardson J.

Vaccine. 2011 Aug 11;29(35):5892-903. doi: 10.1016/j.vaccine.2011.06.071. Epub 2011 Jul 1.

PMID:
21723900
14.

Induction of CTL and nonpolarized Th cell responses by CD8alpha(+) and CD8alpha(-) dendritic cells.

Schlecht G, Leclerc C, Dadaglio G.

J Immunol. 2001 Oct 15;167(8):4215-21.

15.

Contribution of direct and cross-presentation to CTL immunity against herpes simplex virus 1.

Jirmo AC, Nagel CH, Bohnen C, Sodeik B, Behrens GM.

J Immunol. 2009 Jan 1;182(1):283-92.

16.

Nucleotide oligomerization binding domain-like receptor signaling enhances dendritic cell-mediated cross-priming in vivo.

Asano J, Tada H, Onai N, Sato T, Horie Y, Fujimoto Y, Fukase K, Suzuki A, Mak TW, Ohteki T.

J Immunol. 2010 Jan 15;184(2):736-45. doi: 10.4049/jimmunol.0900726. Epub 2009 Dec 11.

17.
18.

CD8- dendritic cells and macrophages cross-present poly(D,L-lactate-co-glycolate) acid microsphere-encapsulated antigen in vivo.

Schliehe C, Redaelli C, Engelhardt S, Fehlings M, Mueller M, van Rooijen N, Thiry M, Hildner K, Weller H, Groettrup M.

J Immunol. 2011 Sep 1;187(5):2112-21. doi: 10.4049/jimmunol.1002084. Epub 2011 Jul 27.

19.

Langerin+ CD8alpha+ dendritic cells are critical for cross-priming and IL-12 production in response to systemic antigens.

Farrand KJ, Dickgreber N, Stoitzner P, Ronchese F, Petersen TR, Hermans IF.

J Immunol. 2009 Dec 15;183(12):7732-42. doi: 10.4049/jimmunol.0902707.

20.

Dendritic cells crosspresent antigens from live B16 cells more efficiently than from apoptotic cells and protect from melanoma in a therapeutic model.

Matheoud D, Baey C, Vimeux L, Tempez A, Valente M, Louche P, Le Bon A, Hosmalin A, Feuillet V.

PLoS One. 2011 Apr 28;6(4):e19104. doi: 10.1371/journal.pone.0019104.

Supplemental Content

Support Center